Introduction
Active implantable medical device such as cardiac pacemakers or implantable cardioverter-defibrillator can be disturbed in its function by electromagnetic fields (EMF). The superposition of the intracardiac ECG and the induced voltages may lead to an incorrect analysis by the implant. In EN 45502-2-1/2 tests for electromagnetic compatibility are defined. However, these tests do not allow any statement about the implant's reaction in real life. We developed a new in vitro test system which identifies the interference reactions and thus allows a risk assessment of electromagnetic interference.
Methods
The core of the new test system is a microcontroller circuit with four digital-to-analog converters for independent signal generation, six analog-to-digital converters and 8 MB SDRAM for signal recording and a USB interface for controlling via computer. It also includes a heart tissue interface corresponding to EN45502-2-1/2, which we optimised for multi chamber implants and low frequency testing. We wrote a software program for the test system which allows determining parameters of the implants, reacting in real time on a stimulation pulse, setting up different test situation and evaluating the implants reaction.
Results
We built an embedded system which simulates realistic human heartbeats including six cardiac dysrhythmia (amplitude up to 40 mV, heart rate 30-200 bpm) and generates disturbances of electromagnetic fields with amplitudes up to +/-40 mV and frequencies up to 250 Hz. Therewith 1-, 2-, 3-chamber devices can be tested in which the atrium, right and left ventricular signals can be separately controlled and overlaid with disturbances.
Conclusion
The new test system allows a risk assessment of interference reactions of multi chamber cardiac implants caused by electromagnetic fields by reproducible, systematic and realistic in vitro tests for the first time. For example it is now possible to evaluate the risk of a hazardous stimulation in the vulnerable phase of the heartbeat.
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